Literature DB >> 22622202

Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition.

Hisashi Shiga1, Takayuki Kajiura, Junko Shinozaki, Sho Takagi, Yoshitaka Kinouchi, Seiichi Takahashi, Kenichi Negoro, Katsuya Endo, Yoichi Kakuta, Manabu Suzuki, Tooru Shimosegawa.   

Abstract

BACKGROUND: Intestinal microbiota contributes to the pathogenesis of Crohn's disease. Elemental diet and total parenteral nutrition are effective therapies for Crohn's disease; however, changes of microbiota as a result of both treatments have not been fully elucidated. AIM: To elucidate changes of faecal microbiota in Crohn's disease patients treated with elemental diet and total parenteral nutrition.
METHODS: Stool samples were collected from 33 active Crohn's disease patients and 17 healthy subjects, and recollected after elemental diet (8 patients) and total parenteral nutrition (9 patients). Terminal restriction fragment length polymorphism analysis of bacterial 16srDNA was performed to evaluate the whole microbiota. Specific quantitative PCR was then used to determine populations of predominant bacterial groups.
RESULTS: In Crohn's disease patients, the number of terminal restriction fragments, which reflects bacterial species, was significantly lower. Populations of total bacteria and Bifidobacterium were significantly lower and the ratio of Enterococcus was higher. The number of terminal restriction fragments was significantly decreased after total parenteral nutrition, but not after elemental diet. Population of Bacteroides fragilis significantly decreased after elemental diet, while population of Enterococcus significantly increased after total parenteral nutrition.
CONCLUSION: Faecal microbiota in Crohn's disease patients was markedly different from healthy subjects. Species diversity was reduced by total parenteral nutrition, but not by elemental diet.
Copyright © 2012 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622202     DOI: 10.1016/j.dld.2012.04.014

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  19 in total

Review 1.  An integrative view of microbiome-host interactions in inflammatory bowel diseases.

Authors:  Marta Wlodarska; Aleksandar D Kostic; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

Review 2.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

Review 3.  Pathogenicity of Enterococci.

Authors:  Elizabeth Fiore; Daria Van Tyne; Michael S Gilmore
Journal:  Microbiol Spectr       Date:  2019-07

4.  Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn's disease: an observational study.

Authors:  C Walton; M P B Montoya; D P Fowler; C Turner; W Jia; R N Whitehead; L Griffiths; R H Waring; D B Ramsden; J A Cole; M Cauchi; C Bessant; S J Naylor; J O Hunter
Journal:  Eur J Clin Nutr       Date:  2016-05-11       Impact factor: 4.016

5.  Reduction in Gut Microbial Diversity as a Mechanism of Action of Exclusive Enteral Nutrition.

Authors:  Nadeem O Kaakoush; Andrew S Day; Steven T Leach; Daniel A Lemberg; Hazel M Mitchell
Journal:  Am J Gastroenterol       Date:  2016-07       Impact factor: 10.864

6.  Bacterial nutrient foraging in a mouse model of enteral nutrient deprivation: insight into the gut origin of sepsis.

Authors:  Matthew W Ralls; Farokh R Demehri; Yongjia Feng; Sasha Raskind; Chunhai Ruan; Arno Schintlmeister; Alexander Loy; Buck Hanson; David Berry; Charles F Burant; Daniel H Teitelbaum
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-01       Impact factor: 4.052

Review 7.  Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.

Authors:  Adi Eindor-Abarbanel; Genelle R Healey; Kevan Jacobson
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

8.  Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease.

Authors:  Nadeem O Kaakoush; Andrew S Day; Steven T Leach; Daniel A Lemberg; Shaun Nielsen; Hazel M Mitchell
Journal:  Clin Transl Gastroenterol       Date:  2015-01-15       Impact factor: 4.488

9.  Surface-Associated Lipoproteins Link Enterococcus faecalis Virulence to Colitogenic Activity in IL-10-Deficient Mice Independent of Their Expression Levels.

Authors:  Soeren Ocvirk; Irina G Sava; Isabella Lengfelder; Ilias Lagkouvardos; Natalie Steck; Jung H Roh; Sandrine Tchaptchet; Yinyin Bao; Jonathan J Hansen; Johannes Huebner; Ian M Carroll; Barbara E Murray; R Balfour Sartor; Dirk Haller
Journal:  PLoS Pathog       Date:  2015-06-12       Impact factor: 6.823

10.  Amniotic fluid protein profiles of intraamniotic inflammatory response to Ureaplasma spp. and other bacteria.

Authors:  Marian Kacerovsky; Peter Celec; Barbora Vlkova; Kristin Skogstrand; David M Hougaard; Teresa Cobo; Bo Jacobsson
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.